Steve Rabin

Steve Rabin is an experienced professional in CMC regulatory affairs, currently serving as Executive Director at Iovance Biotherapeutics, Inc. Previously, Steve held positions as Senior Director and Associate Director of CMC Regulatory Affairs at Janssen, the pharmaceutical division of Johnson and Johnson. Additionally, Steve has worked as a Principal at SBR Consulting, a Senior Scientist under contract at Proteus Biomedical, and as Principal Scientist in Electrotransport Development at ALZA, a Johnson & Johnson company.